Published in Br J Haematol on November 11, 2008
A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. ScientificWorldJournal (2012) 1.67
Solitary plasmacytoma of the jaw. J Blood Med (2010) 1.46
Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database. J Hematol Oncol (2009) 1.16
Total spondylectomy for solitary bone plasmacytoma of the lumbar spine in a young woman: a case report and review of literature. Eur Spine J (2013) 0.98
Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literature. Urol Ann (2015) 0.97
Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant (2013) 0.92
Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases. Diagn Pathol (2011) 0.90
Subcutaneous plasmacytoma metastasis precipitated by tunneled central venous catheter insertion. Case Rep Oncol (2011) 0.88
EBV-positive plasmacytoma of the submandibular gland--report of a rare case with molecular genetic characterization. Head Neck Pathol (2011) 0.87
Maxillary pain is the first indication of the presence of multiple myeloma: A case report. Mol Clin Oncol (2013) 0.86
Extramedullary plasmacytoma of the nasal cavity report of three cases with review of the literature. Iran Red Crescent Med J (2013) 0.86
Primary plasmacytoma of the testicle: a case report. J Med Case Rep (2011) 0.84
Unicentric mixed variant Castleman disease associated with intrabronchial plasmacytoma. Diagn Pathol (2014) 0.84
Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy. Clin Dev Immunol (2012) 0.83
Prognostic factors associated with solitary plasmacytoma. Onco Targets Ther (2013) 0.82
Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study. PLoS One (2013) 0.82
Multiple Myeloma presenting as sacroiliac joint pain: a case report. J Can Chiropr Assoc (2012) 0.81
Multiple Myeloma, Version 2.2016. J Natl Compr Canc Netw (2015) 0.81
Extramedullary plasmacytoma of the frontal sinus: case report and Turkish literature review. Turk J Haematol (2014) 0.80
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol (2011) 0.80
Solitary plasmacytoma of the cecum and the ascending colon: surgical resection as a treatment modality. Case Rep Surg (2015) 0.80
Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer (2017) 0.77
Plasmacytoma of the nasolacrimal duct simulating dacryocystitis: an uncommon presentation for extramedullary relapse of multiple myeloma. Case Rep Oncol (2012) 0.77
Solitary Bone Plasmacytoma of the Pelvis: A Rare Tumor. Rare Tumors (2016) 0.75
Back pain caused by a solitary plasmacytoma of bone. Clin J Oncol Nurs (2010) 0.75
Prognostic factors influencing survival in solitary plasmacytoma. Br J Haematol (2008) 0.75
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography imaging of extra-medullary plasmacytoma of the ovary. Indian J Nucl Med (2013) 0.75
Incidental Plasmacytoma in a Patient With Pathologic Fractures. ACG Case Rep J (2014) 0.75
Apparent diffusion coefficient map of a case of extramedullary plasmacytoma. J Radiol Case Rep (2016) 0.75
An unusual cause of suicidal ideations. Oxf Med Case Reports (2015) 0.75
Extramedullary plasmacytoma of the tonsil with nodal involvement. Int J Otolaryngol (2010) 0.75
Solitary extramedullary plasmacytoma of the penis. Urol Ann (2014) 0.75
Bilateral extramedullary adrenal plasmacytoma: case report and review of the literature. Int J Endocr Oncol (2017) 0.75
An unusual presentation of multiple myeloma with unilateral sudden vision loss: A case report. Medicine (Baltimore) (2017) 0.75
Extramedullary Solitary Plasmacytoma: Demonstrating the Role of (18)F-FDG PET Imaging. J Clin Diagn Res (2017) 0.75
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol (2003) 14.41
Improved survival in multiple myeloma and the impact of novel therapies. Blood (2007) 12.70
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer (1999) 6.86
The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore) (1976) 5.03
Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood (2007) 4.08
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol (2007) 3.32
Clinical outcome of extramedullary plasmacytoma. Haematologica (2000) 3.27
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood (2005) 3.25
Graphical presentation of trends in rates. Am J Epidemiol (1995) 3.09
Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc (2007) 2.91
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol (2004) 2.91
Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood (2000) 2.87
Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol (1983) 2.71
Plasmacytoma. Treatment results and conversion to myeloma. Cancer (1992) 2.50
Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer (1981) 2.23
Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol (1999) 2.05
Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer (1995) 2.04
Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood (2006) 1.98
Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer (2006) 1.68
Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys (1996) 1.60
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys (1998) 1.56
Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am (1992) 1.55
Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys (2005) 1.53
Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys (1989) 1.51
Extramedullary plasmacytoma of the head and neck, parotid and submandibular salivary glands. J Laryngol Otol (1977) 1.50
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol (1995) 1.49
Extramedullary plasmacytoma: clinical and histopathologic study. Int J Radiat Oncol Biol Phys (2002) 1.39
The statistical comparison of relative survival rates. Biometrics (1983) 1.34
Radiotherapy in the management of solitary extramedullary plasmacytoma. Intern Med J (2005) 1.31
Solitary plasmacytoma of bone: treatment, progression, and survival. J Clin Oncol (1987) 1.21
Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica (2008) 1.17
Extramedullary plasmacytomas and solitary plasma cell tumours of bone. Eur J Haematol (1990) 1.07
Prognostic significance of osteopenia and immunoparesis at presentation in patients with solitary myeloma of bone. Eur J Cancer (1990) 1.06
Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States). Cancer Causes Control (2006) 1.02
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med (2003) 6.06
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst (2005) 4.14
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol (2007) 3.32
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood (2011) 3.30
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood (2005) 3.25
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology (2005) 3.24
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24
Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst (2006) 3.17
Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol (2005) 3.01
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer (2012) 2.95
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol (2005) 2.85
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer (2006) 2.73
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood (2009) 2.73
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol (2002) 2.63
Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst (2004) 2.60
Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat (2005) 2.57
Solid cancers after allogeneic hematopoietic cell transplantation. Blood (2008) 2.56
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood (2011) 2.54
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA (2007) 2.51
Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev (2009) 2.50
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid (2010) 2.48
US lung cancer trends by histologic type. Cancer (2014) 2.46
Trends in the incidence of testicular germ cell tumors in the United States. Cancer (2003) 2.45
Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med (2012) 2.45
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst (2002) 2.44
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol (2011) 2.34
Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23
Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case-control study. BMJ (2011) 2.21
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood (2010) 2.21
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood (2009) 2.16
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer (2007) 2.16
Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol (2011) 2.16
Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study. Hepatology (2014) 2.14
Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood (2010) 2.12
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol (2011) 2.11
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood (2010) 2.10
Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer (2003) 2.08
International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev (2010) 2.07
Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell (2013) 2.06
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol (2007) 2.02
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis (2012) 2.01
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer (2009) 2.01
Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med (2004) 2.00
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
A geographic analysis of prostate cancer mortality in the United States, 1970-89. Int J Cancer (2002) 1.94
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood (2010) 1.89
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol (2009) 1.88
Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev (2011) 1.86
New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer (2007) 1.85
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer (2003) 1.85
Rising prostate cancer rates in South Korea. Prostate (2006) 1.83
Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst (2010) 1.81
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology (2009) 1.80
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood (2008) 1.78
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst (2002) 1.77
Minimal residual disease: what are the minimum requirements? J Clin Oncol (2014) 1.76
Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet (2013) 1.74
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol (2009) 1.74
Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer (2008) 1.74
Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control (2003) 1.72
Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68
Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology (2012) 1.68
Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat (2004) 1.67
Comparison of occupational exposure assessment methods in a case-control study of lead, genetic susceptibility and risk of adult brain tumours. Occup Environ Med (2010) 1.66
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood (2013) 1.64
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood (2013) 1.64
Brain cancer incidence trends in relation to cellular telephone use in the United States. Neuro Oncol (2010) 1.63